Knowledge Sharing
How to Reduce Waste and Costs in Clinical Trial Supply
As of 2021, the average waste rate for IMP distribution was alarmingly high, approaching 50%. This raises the critical question: are there strategies available to reduce both waste and costs, while simultaneously ensuring the vital aspect of supply security? Explore innovative approaches to optimize clinical trial supply management, minimizing waste and expenses without compromising supply security.
Download this resource to discover:
- Optimize Clinical Supply Chains: Leverage modern RTSM platforms and demand forecasting tools to reduce IMP waste and improve supply efficiency.
- Achieve Cost and Risk Balance: Utilize automated forecasting algorithms to ensure optimal stock levels, reducing missed patient visits and excess inventory.
- Streamline Depot Resupply: Implement advanced forecasting to dynamically calculate trigger points and resupply quantities, minimizing overstocking and waste.